buprenorphine

Only 1 in 4 Opioid-Addicted Youth Receive Medication
Only 1 in 4 Opioid-Addicted Youth Receive MedicationYounger people, females, black or Hispanic less likely to have medication.
Fourteen things Trump needs to know about opioidsAs President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
Opinion: Substance use disorder privacy law limits both payers, prescribersTwo University of Massachusetts Medical School pharmacists make the case to reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder.
Prescribing practices that increase risk of opioid overdoseTwo studies, one from Prime Therapeutics and Stanford, reveal an alarming increase in overdose with concurrent use of opioids and benzodiazepines. Here’s how managed care can help.
More resources needed for medication-assisted treatmentInclude medication-assisted treatment high on the list of clinical tools used to treat opioid addiction.
Four developments helping address the opioid epidemicAs the opioid epidemic continues across the U.S., new treatment programs and guidelines could help reverse the trend.
Top 4 ways US is combating opioid epidemic
Top 4 ways US is combating opioid epidemicExpanding access to buprenorphine, a medication to treat opioid use disorder, is one of several new actions announced by Health and Human Services (HHS) to combat the opioid epidemic. Here are the top 4 new provisions from HHS.
Pharmacists should get training in naloxone use nowPharmacists are the most accessible healthcare resource. Once trained in naloxone use, we can train our patients in all aspects of opioid use. This will make a difference.
HHS tackles opioid epidemicHHS is taking formal steps to address opioid addiction, a widely recognized national public health crisis. Find out the policy changes.
Will price impede recently approved implant for opioid addicts?Probuphine implant could be a new option for addicts if obstacles, such as price, don’t get in the way.